USA — Moderna, the mRNA vaccine and therapeutics developer, has announced its growth plans, which include global expansion and the hiring of approximately 2,000 new employees worldwide by the end…
Read MoreTag: Moderna
Moderna expands operations to Oxfordshire with new research and manufacturing site
UNITED KINGDOM — Moderna has announced that it will construct a new research and manufacturing site, the Moderna Innovation and Technology Center (MITC), in Oxfordshire, UK. The MITC will be…
Read MoreMixed results for Moderna’s influenza mRNA vaccine candidate
USA — Moderna, a US biotech firm has announced mixed findings from a large-scale trial of its mRNA flu shot, which employs the same technology as its effective Covid-19 vaccine.…
Read MoreModerna looks to expand its manufacturing footprint globally
USA — Moderna CEO Stéphane Bancel stated this week at the World Economic Forum Annual Meeting that the company intends to build on its exponential growth during the pandemic by…
Read MoreModerna RSV vaccine shows 84% efficacy in preventing symptoms in older adults, pitting it in a race with GSK, Pfizer
USA — Moderna has announced that its experimental messenger RNA vaccine for respiratory syncytial virus (RSV) was 83.7% effective in preventing at least two symptoms, such as cough and fever,…
Read MoreModerna to acquire Japanese DNA manufacturer OriCiro for US$85M
JAPAN – Moderna Inc. has struck a deal to buy OriCiro Genomics K.K., a pioneer in cell-free DNA synthesis and amplification technologies, for US$85 million in cash. The biotechnology company…
Read MoreModerna strikes US$35M scientific research deal with Cytomx
USA – Moderna Inc. has entered into a strategic collaboration and licensing pact worth up to US$35 million with CytomX Therapeutics Inc., a leader in the field of conditionally activated…
Read MoreModerna’s mRNA cancer vaccine shows promise in early trial with Merck’s Keytruda
USA —A personalized Moderna Inc. cancer vaccine combined with collaborator Merck & Co.’s best-selling drug reduced melanoma deaths in a mid-stage trial, easing concerns about the biotechnology company’s second act…
Read MoreMerck and Moderna to jointly develop and sell cancer vaccine
USA — Merck & Co. has exercised a US$250-million option with Moderna to jointly develop and commercialize personalized mRNA cancer vaccine candidates. Merck & Co. will pay Moderna US$250 million…
Read MoreFDA authorizes COVID-19 vaccines for use as a booster dose in kids as young as 5
USA – The United States FDA (US FDA) has authorized updated COVID-19 boosters for children as young as five, seeking to broaden protection ahead of an expected winter storm. The…
Read More